bioRxiv Science⌕ Search

Biology subjects

Large, A.

Publications and source records attributed to Large, A..

2 recordsLinked to original sources

Nested birth-death processes are competitive with parameter-heavy neural networks as time-dependent models of protein evolution

Most statistical phylogenetics analyses use relatively simple continuous-time finite-state Markov models of point substitution to describe molecular evolution, often keeping sequence length fixed, ignoring insertions and deletions (indels) entirely, and making little (if any) allowance for variations in selection pressure due to interactions between amino acids. The simplistic assumptions of these models limit the realism of phylogenetics. We extend the TKF92 model - the canonical hierarchical model combining an outer birth-death process for indels with an inner finite-state Markov chain for substitutions - by introducing additional nesting and latent states, allowing for structural heterogeneity. We compare these TKF92 extensions (which are derived as exact solutions of instantaneous processes, and in which evolutionary time naturally appears as a matrix exponential coefficient) to two classes of neural seq2seq model that are not derived in such a way, but instead take evolutionary time as an input feature: the first class of model being constrained to enforce a TKF92-like structure, and the second lacking any such constraint. We evaluate the per-character perplexities of all models on splits of the PFam database of aligned protein domains. A nested TKF-based model with only 32,000 parameters is highly competitive with neural networks containing tens of millions of parameters, outperforming all but two of the neural architectures tested. Our results indicate that approaches grounded in molecular evolutionary theory may be more parameter-efficient and provide a better fit to real alignments than unconstrained alternatives, supporting the incorporation of CTMC-based model structure within future neural phylogenetic approaches.

bioinformatics↗

Rapid Liquid Chromatography-Mass Spectrometry (rLC-MS) for Deep Metabolomics Analysis of Population Scale Studies

Mass spectrometry (MS)-based metabolomics is a key technology for the interrogation of exogenous and endogenous small molecule mediators that influence human health and disease. To date, however, low throughput of MS systems have largely precluded large-scale metabolomics studies of human populations, limiting power to discover physiological roles of metabolites. Here, we introduce a fully automated rapid liquid chromatography-mass spectrometry (rLC-MS) system coupled to an AI-enabled computational pipeline that enables high-throughput, reproducible, non-targeted metabolite measurements across tens of thousands of samples. This system captures thousands of polar, amphipathic and nonpolar (lipid) metabolites in a human plasma sample in 53 seconds of analytical time, enabling analysis of greater than 1,000 samples per day per instrument. To demonstrate the discovery power of the rLC-MS platform, a subset of samples from Sapients DynamiQ biorepository - comprised of 62,039 total plasma samples collected longitudinally from 11,045 individuals - were selected for deep analysis by rLC-MS to capture a rich, dynamic landscape of chemical variation that reflects both physiological processes and environmental influences. 26,042 plasma samples with matched real-world data (RWD) were chosen for the study, representing 6,935 individuals with diverse demographic backgrounds and disease profiles. Unbiased exploratory analysis revealed human metabotypes that correlate with heterogenous disease phenotypes, including key sub-populations of cardiometabolic and other human diseases. Moreover, a metabolic aging clock machine learning model trained on healthy individuals in this dataset accurately predicted accelerated aging in various chronic diseases, with dynamic reversal of metabolic aging following definitive therapy. These data demonstrate that the rLC-MS platform enables prediction of clinically relevant physiological states from plasma metabolomics at scale in human populations.

biochemistry↗